{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:58:42Z","timestamp":1787061522709,"version":"build-2736575974"},"reference-count":68,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Kidney transplantation (KT) represents a pivotal intervention for patients with chronic kidney disease (CKD), significantly improving survival and quality of life. However, KT recipients face an array of non-immunological complications, collectively amplifying cardiovascular (CV) and metabolic risks. This review explores the intersection of cardio-metabolic syndrome and KT, emphasizing the recently introduced cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome. CKM syndrome integrates metabolic risk factors, CKD, and CV disease, with KT recipients uniquely predisposed due to immunosuppressive therapies and pre-existing CKD-related risks. Key issues include post-transplant hypertension, obesity, dyslipidemia, post-transplant diabetes mellitus (PTDM), and anemia. Immunosuppressive agents such as corticosteroids, calcineurin inhibitors, and mTOR inhibitors contribute significantly to these complications, exacerbating metabolic dysfunction, insulin resistance, and lipid abnormalities. For instance, corticosteroids and calcineurin inhibitors heighten the risk of PTDM, while mTOR inhibitors are strongly associated with dyslipidemia. These pharmacologic effects underscore the need for tailored immunosuppressive strategies. The management of these conditions requires a multifaceted approach, including lifestyle interventions, pharmacological therapies like SGLT2 inhibitors and GLP-1 receptor agonists, and close monitoring. Additionally, emerging therapies hold promise in addressing metabolic complications in KT recipients. Proactive risk stratification and early intervention are essential to mitigating CKM syndrome and improving outcomes. This comprehensive review highlights the importance of integrating cardio-metabolic considerations into KT management, offering insights into optimizing long-term recipient health and graft survival.<\/jats:p>","DOI":"10.3390\/jcm14062101","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:38:48Z","timestamp":1742380728000},"page":"2101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Kidney Transplant: More than Immunological Problems"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5329-5189","authenticated-orcid":false,"given":"Rosana","family":"Gelpi","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Casas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Taco","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-9383","authenticated-orcid":false,"given":"Maya","family":"Sanchez-Baya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Nassiri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Bolufer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0033-4214","authenticated-orcid":false,"given":"Maria","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ca\u00f1as","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vila","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Ara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-2273","authenticated-orcid":false,"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain"},{"name":"Redes de Investigaci\u00f3n Cooperativa Orientadas a Resultados en Salud (RICORS) 2040, 28029 Badalona, Spain"},{"name":"Germans Trias i Pujol Health Sciences Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/ndt\/gfad115","article-title":"Clinical implications of changes in metabolic syndrome status after kidney transplantation: A nationwide prospective cohort study","volume":"38","author":"Lee","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"American Heart Association.Cardiovascular-kidney-metabolic health: A Presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nefro.2024.05.001","article-title":"La definici\u00f3n del s\u00edndrome cardiovascular-reno-metab\u00f3lico (cardiovascular-kidney-metabolic syndrome) y su papel en la prevenci\u00f3n, estatificaci\u00f3n del riesgo y tratamiento. Una oportunidad para la Nefrolog\u00eda","volume":"44","author":"Cases","year":"2024","journal-title":"Nefrologia"},{"key":"ref_4","unstructured":"Lorenzo, V., and L\u00f3pez G\u00f3mez, J.M. (2022). Complicaciones Cardiovasculares en el Trasplante Renal. Nefrolog\u00eda al d\u00eda, Elsevier."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41371-021-00540-5","article-title":"Role of hypertension in kidney transplant recipients","volume":"35","author":"Loutradis","year":"2021","journal-title":"J. Hum. Hypertens."},{"key":"ref_7","first-page":"589","article-title":"Effect of weight change after renal transplantation on outcomes of graft survival","volume":"41","author":"Arnaldo","year":"2022","journal-title":"Nefrolog\u00eda"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ndt\/gfac169","article-title":"Retrospective analysis of the impact of severe obesity on kidney transplant outcomes","volume":"38","author":"Tsapepas","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOT.0000000000001050","article-title":"Obesity and kidney transplantation","volume":"28","author":"Chang","year":"2023","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yemini, R., Rahamimov, R., Nesher, E., Anteby, R., Ghinea, R., Hod, T., and Mor, E. (2022). The impact of obesity and associated comorbidities on the outcomes after renal transplantation with a living donor vs. deceased donor grafts. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113069"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1159\/000515786","article-title":"Obesity in renal transplantation","volume":"145","author":"Quero","year":"2021","journal-title":"Nephron"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfab277","article-title":"Impact of obesity in kidney transplantation: A prospective cohort study from French registries between 2008 and 2014","volume":"37","author":"Pereira","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.acuroe.2023.08.007","article-title":"Does obesity really affect renal transplantation outcomes?","volume":"48","author":"Pietropaolo","year":"2024","journal-title":"Actas Urol. Espa\u00f1."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: An observational multicentre study","volume":"16","author":"Vega","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Polychronopoulou, E., Bourdon, F., and Teta, D. (2024). SGLT2 inhibitors in diabetic and non-diabetic kidney transplant recipients: Current knowledge and expectations. Front. Nephrol., 4.","DOI":"10.3389\/fneph.2024.1332397"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.transproceed.2024.02.026","article-title":"Combination of SGLT2 inhibitors and GLP-1 receptor agonists in PTDM treatment in kidney transplant recipients: Synergistic effect with added value in terms of nephroprotection","volume":"56","author":"Juric","year":"2024","journal-title":"Transplant. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rudzki, G., Knop-Chody\u0142a, K., Piasecka, Z., Kochanowska-Mazurek, A., G\u0142az, A., Weso\u0142ek-Bielaska, E., and Wozniak, M. (2024). Managing Post-Transplant Diabetes Mellitus after Kidney Transplantation: Challenges and Advances in Treatment. Pharmaceuticals, 17.","DOI":"10.3390\/ph17080987"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Sun, J., Guo, M., and Yuan, X. (2023). Progress of new-onset diabetes after liver and kidney transplantation. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1091843"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee 2 (2024). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care, 47, S20\u2013S42.","DOI":"10.2337\/dc24-S002"},{"key":"ref_20","unstructured":"Solhjoo, M., and Kumar, S.C. (2024). New Onset Diabetes After Transplant. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Katwal, P.C., Jirjees, S., Htun, Z.M., Aldawudi, I., and Khan, S. (2020). The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes. Cureus, 12.","DOI":"10.7759\/cureus.8431"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/tri.12042","article-title":"Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation","volume":"26","author":"Shabir","year":"2013","journal-title":"Transplant. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/TP.0000000000001453","article-title":"Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression with 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial","volume":"101","author":"Mourad","year":"2017","journal-title":"Transplantation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Thomas, M.C., Moran, J., Mathew, T.H., Russ, G.R., and Rao, M.M. (2000). Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol., 1.","DOI":"10.1186\/1471-2369-1-1"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Alajous, S., and Budhiraja, P. (2024). New-Onset Diabetes Mellitus after Kidney Transplantation. J. Clin. Med., 13.","DOI":"10.20944\/preprints202402.0314.v1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/dc12-1894","article-title":"Pancreatic \u03b2-cell dysfunction and risk of new-onset diabetes after kidney transplantation","volume":"36","author":"Zelle","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/diab.44.5.555","article-title":"Skeletal Muscle GLUT4 Protein Concentration and Aging in Humans","volume":"44","author":"Houmard","year":"1995","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","article-title":"Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-8587(15)00387-3","article-title":"Post-transplantation diabetes-State of the art","volume":"4","author":"Sharif","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_31","first-page":"378","article-title":"Glucocorticoids and Diabetes","volume":"113","author":"Bauerle","year":"2016","journal-title":"Mo. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Alfieri, C., Favi, E., Campioli, E., Cicero, E., Molinari, P., Campise, M., Gandolfo, M.T., Regalia, A., Cresseri, D., and Messa, P. (2022). Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: ASingle-Center Retrospective Observational Cohort Study. Medicina, 58.","DOI":"10.3390\/medicina58111608"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic \u03b2 Cells","volume":"17","author":"Wagner","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Terrec, F., Jouve, T., Naciri-Bennani, H., Benhamou, P.Y., Malvezzi, P., Janbon, B., Giovannini, D., Rostaing, L., and Noble, J. (2019). Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters. Transplant. Direct., 6.","DOI":"10.1097\/TXD.0000000000000964"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.healun.2022.07.011","article-title":"Posttransplant diabetes mellitus following heart transplantation","volume":"41","author":"Newman","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/TP.0000000000002769","article-title":"Mammalian Target of Rapamycin Inhibitors Combined with Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis","volume":"103","author":"Montero","year":"2019","journal-title":"Transplantation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ndt\/gfad258","article-title":"International consensus on post-transplantation diabetes mellitus","volume":"39","author":"Sharif","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ponticelli, C., Favi, E., and Ferraresso, M. (2021). New-Onset Diabetes after Kidney Transplantation. Medicina, 57.","DOI":"10.3390\/medicina57030250"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1210\/clinem\/dgad395","article-title":"Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia","volume":"109","author":"Cusi","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.transproceed.2014.07.011","article-title":"Diabetes mellitus and renal transplantation in adults: Is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?","volume":"46","author":"Suarez","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trre.2013.12.004","article-title":"Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment","volume":"28","author":"Wissing","year":"2014","journal-title":"Transplant. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4158\/EP151039.RA","article-title":"Hyperglycemia management in patients with posttransplantation diabetes","volume":"22","author":"Galindo","year":"2016","journal-title":"Endocr.Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ajt.12518","article-title":"Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation\u2014A randomized, double-blind, placebo-controlled trial","volume":"14","author":"Haidinger","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/TP.0000000000004373","article-title":"Sitagliptin Versus Placebo to Reduce the Incidence and Severity of Posttransplant Diabetes Mellitus After Kidney Transplantation-A Single-center, Randomized, Double-blind Controlled Trial","volume":"107","author":"Hagopian","year":"2023","journal-title":"Transplantation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: Results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/ndt\/gfae032","article-title":"How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial. Nephrol Dial Transplant","volume":"39","author":"Wanner","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1681\/ASN.2020050723","article-title":"Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial","volume":"31","author":"Oshima","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: A prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: Immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transplant. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5507\/bp.2016.005","article-title":"New-onset diabetes mellitus after renal transplantation","volume":"160","author":"Goldmannova","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000541910","article-title":"Analysis of the Correlation between Hypercholesterolemia and Increased Cardiovascular Morbidity and Mortality among Adult Kidney Transplant Recipients","volume":"49","author":"Nagel","year":"2024","journal-title":"Kidney Blood Press. Res."},{"key":"ref_54","first-page":"1072","article-title":"Impact of tacrolimus versus cyclosporine on lipid metabolism and cardiovascular risk in kidney transplant recipients","volume":"52","author":"Soveri","year":"2020","journal-title":"Transplant. Proc."},{"key":"ref_55","first-page":"1401","article-title":"Statin therapy in kidney transplant recipients: A meta-analysis of randomized controlled trials","volume":"53","author":"Sampaio","year":"2021","journal-title":"Transplant. Proc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12944-024-02276-w","article-title":"Efficacy and safety of statin therapy in kidney transplant recipients: A systematic review and meta-analysis","volume":"23","author":"Bellos","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_57","first-page":"11","article-title":"PCSK9 inhibitors in kidney transplant recipients: A systematic review","volume":"16","author":"Wu","year":"2022","journal-title":"J. Clin. Lipidol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1034\/j.1600-6143.2002.20506.x","article-title":"Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?","volume":"2","author":"Yorgin","year":"2002","journal-title":"Am. J. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1034\/j.1600-6143.2003.00174.x","article-title":"Anemia after kidney transplantation\u2014Is the incidence increasing?","volume":"3","author":"Hricik","year":"2003","journal-title":"Am. J. Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: A European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am. J. Transplant."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.transproceed.2004.11.081","article-title":"Iron deficiency\u2014An underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: Risks and effects of ACEI and of iron treatment","volume":"37","author":"Jimeno","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1681\/ASN.V133794","article-title":"Anemia and iron deficiencies among long-term renal transplant recipients","volume":"13","author":"Lorenz","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Huang, G., Wu, L.W., Yang, S.C., Fei, J.Q., Deng, S.X., Li, J., Chen, G., Fu, Q., Deng, R., and Qiu, J. (2015). Factors influencing graft outcomesfollowing diagnosis of polyomavirus-associated nephropathy after renal transplantation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142460"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1111\/ctr.12220","article-title":"Anemia is a predictor of graftloss but not cardiovascular events and all-cause mortality in renal transplant recipients: Follow-up data from the ALERT study","volume":"27","author":"Schjelderup","year":"2013","journal-title":"Clin. Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","volume":"Volume 10","author":"Rossing","year":"2020","journal-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes and CKD: Kidney International Supplements"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"760","DOI":"10.33963\/v.phj.101062","article-title":"Comprehensive assessment of cardiovascular-kidney-metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients","volume":"82","author":"Batko","year":"2024","journal-title":"Kardiol. Pol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/2101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:56:38Z","timestamp":1760028998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/2101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14062101"],"URL":"https:\/\/doi.org\/10.3390\/jcm14062101","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}